Detection of Female Sexual Dysfunction

Thumbnail Image
Otto, Terri
Issue Date
Method: This project aimed to increase the number of screenings conducted for female sexual dysfunction at a rural women’s health clinic in NC. The Female Sexual Function Index (FSFI-6) tool was used during annual physical exams and for patients taking antidepressants. If the screening results were positive, patients were offered treatment, and an FSFI-6 posttest was conducted during a follow-up appointment scheduled after two to three months. Additionally, a demographic survey was also completed. Results: Ninety one percent of the participants experienced female sexual dysfunction and half of the participants were taking antidepressants. An ANOVA analysis revealed a significant difference between the total FSFI-6 scores and the use of antidepressants (p-value=0.024), indicating that patients taking antidepressants were more likely to have female sexual dysfunction. Another ANOVA analysis showed a significant difference between the total posttest FSFI-6 scores and antidepressant use (p-value .046). These results suggest that a intervention change in antidepressants can improve FSFI-6 scores. Conclusion: Using the FSFI-6 assessment tool and providing intervention for female patients taking antidepressants can help in improving female sexual dysfunction in daily practice. As a result of this project, there was a 100% increase in the number of screenings.